Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Financial Costs Incurred by Living Kidney Donors: A Prospective Cohort Study.

Przech S, Garg AX, Arnold JB, Barnieh L, Cuerden MS, Dipchand C, Feldman L, S Gill J, Karpinski M, Knoll G, Lok C, Miller M, Monroy M, Nguan C, Prasad GVR, Sarma S, Sontrop JM, Storsley L, Klarenbach S; Donor Nephrectomy Outcomes Research (DONOR) Network.

J Am Soc Nephrol. 2018 Nov 7. pii: ASN.2018040398. doi: 10.1681/ASN.2018040398. [Epub ahead of print]

PMID:
30404908
2.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Oct;72(4):483-498. doi: 10.1053/j.ajkd.2018.01.036. Epub 2018 Mar 24.

3.

Impact of Exercise Counseling on Physical Function in Chronic Kidney Disease: An Observational Study.

Bohm CJ, Storsley LJ, Hiebert BM, Nelko S, Tangri N, Cheskin LJ, McAdams-DeMarco MA, Rigatto C.

Can J Kidney Health Dis. 2018 Feb 19;5:2054358117753615. doi: 10.1177/2054358117753615. eCollection 2018.

4.

Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.

Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, Goldberg A, Ho J, Karpinski M, Pochinco D, Sharma A, Storsley L, Matas AJ, Nickerson PW.

J Am Soc Nephrol. 2017 Nov;28(11):3353-3362. doi: 10.1681/ASN.2017030287. Epub 2017 Jul 20.

5.

Cognitive Impairment in Advanced Chronic Kidney Disease: The Canadian Frailty Observation and Interventions Trial.

Foster R, Walker S, Brar R, Hiebert B, Komenda P, Rigatto C, Storsley L, Prasad B, Bohm C, Tangri N.

Am J Nephrol. 2016;44(6):473-480. Epub 2016 Nov 1.

PMID:
27798938
6.

Evaluation of C1q Status and Titer of De Novo Donor-Specific Antibodies as Predictors of Allograft Survival.

Wiebe C, Gareau AJ, Pochinco D, Gibson IW, Ho J, Birk PE, Blydt-Hansen T, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.

Am J Transplant. 2017 Mar;17(3):703-711. doi: 10.1111/ajt.14015. Epub 2016 Oct 3.

7.

Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.

Ho J, Sharma A, Mandal R, Wishart DS, Wiebe C, Storsley L, Karpinski M, Gibson IW, Nickerson PW, Rush DN.

Transplant Direct. 2016 May 19;2(6):e78. doi: 10.1097/TXD.0000000000000589. eCollection 2016 Jun.

8.

The assessment of frailty in older people with chronic kidney disease.

Bohm C, Storsley L, Tangri N.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):498-504. doi: 10.1097/MNH.0000000000000163. Review.

PMID:
26447796
9.

Kidney Paired Donation Protocol for Participating Donors 2014.

Richardson R, Connelly M, Dipchand C, Garg AX, Ghanekar A, Houde I, Johnston O, Mainra R, McCarrell R, Mueller T, Nickerson P, Pippy C, Storsley L, Tinckam K, Wright L, Yilmaz S, Landsberg D; Protocols Working Group of the Canadian Blood Services’ Living Donation Advisory Committee.

Transplantation. 2015 Oct;99(10 Suppl 1):S1-S88. doi: 10.1097/TP.0000000000000918. No abstract available.

PMID:
26425842
10.

Frailty and physical function in chronic kidney disease: the CanFIT study.

Walker SR, Brar R, Eng F, Komenda P, Rigatto C, Prasad B, Bohm CJ, Storsley LJ, Tangri N.

Can J Kidney Health Dis. 2015 Sep 5;2:32. doi: 10.1186/s40697-015-0067-4. eCollection 2015.

11.

Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.

Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.

Am J Transplant. 2015 Nov;15(11):2921-30. doi: 10.1111/ajt.13347. Epub 2015 Jun 10.

12.

Gestational hypertension and preeclampsia in living kidney donors.

Garg AX, Nevis IF, McArthur E, Sontrop JM, Koval JJ, Lam NN, Hildebrand AM, Reese PP, Storsley L, Gill JS, Segev DL, Habbous S, Bugeja A, Knoll GA, Dipchand C, Monroy-Cuadros M, Lentine KL; DONOR Network.

N Engl J Med. 2015 Jan 8;372(2):124-33. doi: 10.1056/NEJMoa1408932. Epub 2014 Nov 14.

13.

Teen donors, adult problems? Evaluating the long-term risks of living kidney donation from adolescents.

Goldberg A, Storsley L.

Pediatr Transplant. 2014 Jun;18(4):319-20. doi: 10.1111/petr.12251. No abstract available.

PMID:
24802337
14.

Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months.

Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN.

Transplantation. 2014 Jul 15;98(1):39-46. doi: 10.1097/01.TP.0000442776.40295.73.

PMID:
24646773
15.

Economic consequences incurred by living kidney donors: a Canadian multi-center prospective study.

Klarenbach S, Gill JS, Knoll G, Caulfield T, Boudville N, Prasad GV, Karpinski M, Storsley L, Treleaven D, Arnold J, Cuerden M, Jacobs P, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2014 Apr;14(4):916-22. doi: 10.1111/ajt.12662. Epub 2014 Mar 5.

16.

Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.

Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW.

Am J Transplant. 2013 Dec;13(12):3114-22. doi: 10.1111/ajt.12478. Epub 2013 Oct 25.

17.

Association of frailty and physical function in patients with non-dialysis CKD: a systematic review.

Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, Bohm CJ, Storsley LJ, Tangri N.

BMC Nephrol. 2013 Oct 22;14:228. doi: 10.1186/1471-2369-14-228. Review.

18.

Young aboriginals are less likely to receive a renal transplant: a Canadian national study.

Promislow S, Hemmelgarn B, Rigatto C, Tangri N, Komenda P, Storsley L, Yeates K, Mojica J, Sood MM.

BMC Nephrol. 2013 Jan 14;14:11. doi: 10.1186/1471-2369-14-11.

19.

Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss.

Ho J, Wiebe C, Rush DN, Rigatto C, Storsley L, Karpinski M, Gao A, Gibson IW, Nickerson PW.

Transplantation. 2013 Feb 27;95(4):595-602. doi: 10.1097/TP.0b013e31826690fd.

PMID:
23192155
20.

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, Goldberg A, Birk PE, Rush DN, Nickerson PW.

Am J Transplant. 2012 May;12(5):1157-67. doi: 10.1111/j.1600-6143.2012.04013.x. Epub 2012 Mar 19.

21.

Cardiovascular disease in kidney donors: matched cohort study.

Garg AX, Meirambayeva A, Huang A, Kim J, Prasad GV, Knoll G, Boudville N, Lok C, McFarlane P, Karpinski M, Storsley L, Klarenbach S, Lam N, Thomas SM, Dipchand C, Reese P, Doshi M, Gibney E, Taub K, Young A; Donor Nephrectomy Outcomes Research Network.

BMJ. 2012 Mar 1;344:e1203. doi: 10.1136/bmj.e1203.

22.

Access to living donor transplantation for Aboriginal recipients: a study of living donor presentation and exclusion.

Dunsmore S, Karpinski M, Young A, Storsley L.

Clin Transplant. 2011 Nov-Dec;25(6):E617-21. doi: 10.1111/j.1399-0012.2011.01491.x. Epub 2011 Sep 15.

PMID:
21919960
23.

Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis.

Ho J, Rush DN, Karpinski M, Storsley L, Gibson IW, Bestland J, Gao A, Stefura W, HayGlass KT, Nickerson PW.

Transplantation. 2011 Oct 27;92(8):878-82. doi: 10.1097/TP.0b013e31822d4de1.

PMID:
21876477
24.

Adenovirus interstitial nephritis and rejection in an allograft.

Storsley L, Gibson IW.

J Am Soc Nephrol. 2011 Aug;22(8):1423-7. doi: 10.1681/ASN.2010090941. Epub 2011 Mar 24.

25.

The long-term quality of life of living kidney donors: a multicenter cohort study.

Clemens K, Boudville N, Dew MA, Geddes C, Gill JS, Jassal V, Klarenbach S, Knoll G, Muirhead N, Prasad GV, Storsley L, Treleaven D, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2011 Mar;11(3):463-9. doi: 10.1111/j.1600-6143.2010.03424.x. Erratum in: Am J Transplant. 2011 Apr;11(4):874. Garg, A [corrected to Garg, A X].

26.

Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.

Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW.

Transplantation. 2010 Aug 27;90(4):394-400. doi: 10.1097/TP.0b013e3181e6424d.

PMID:
20625355
27.

Long-term medical outcomes among Aboriginal living kidney donors.

Storsley LJ, Young A, Rush DN, Nickerson PW, Ho J, Suon V, Karpinski M.

Transplantation. 2010 Aug 27;90(4):401-6. doi: 10.1097/TP.0b013e3181e6e79b.

PMID:
20562735
28.

A protocolized approach to vancomycin dosing in conventional hemodialysis.

Panais R, Hirsch DJ, Dipchand C, Storsley L, Finkle SN.

J Nephrol. 2010 Sep-Oct;23(5):569-74.

PMID:
20540035
29.

Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada.

Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM, Knoll G, Karpinski M, Parikh CR, Gill J, Storsley L, Vlasschaert M, Mamdani M; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2008 Aug 15;86(3):399-406. doi: 10.1097/TP.0b013e31817ba9e3.

PMID:
18698242
30.

Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review.

Young A, Storsley L, Garg AX, Treleaven D, Nguan CY, Cuerden MS, Karpinski M.

Am J Transplant. 2008 Sep;8(9):1878-90. doi: 10.1111/j.1600-6143.2008.02339.x. Epub 2008 Jul 28. Review.

31.

Do biochemical measures change in living kidney donors? A systematic review.

Young A, Nevis IF, Geddes C, Gill J, Boudville N, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Nephron Clin Pract. 2007;107(3):c82-9. Epub 2007 Sep 21. Review.

PMID:
17890875
32.

Improving on-line information for potential living kidney donors.

Moody EM, Clemens KK, Storsley L, Waterman A, Parikh CR, Garg AX; Donor Nephrectomy Outcomes Research (Donor) Network.

Kidney Int. 2007 May;71(10):1062-70. Epub 2007 Mar 14.

33.

Ciprofloxacin-induced ANCA-negative cutaneous and renal vasculitis--resolution with drug withdrawal.

Storsley L, Geldenhuys L.

Nephrol Dial Transplant. 2007 Feb;22(2):660-1. Epub 2006 Sep 5. No abstract available.

PMID:
16954175
34.

IgM monoclonal protein presenting as pseudohypercreatininaemia.

Storsley L, Fine A, Krahn J.

Nephrol Dial Transplant. 2006 Nov;21(11):3337-8. Epub 2006 Jul 5. No abstract available.

PMID:
16822783
35.

The impact of accepting living kidney donors with mild hypertension or proteinuria on transplantation rates.

Karpinski M, Knoll G, Cohn A, Yang R, Garg A, Storsley L.

Am J Kidney Dis. 2006 Feb;47(2):317-23.

PMID:
16431261
36.

Severe lactic acidosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin.

Guo PY, Storsley LJ, Finkle SN.

Semin Dial. 2006 Jan-Feb;19(1):80-3.

PMID:
16423187

Supplemental Content

Loading ...
Support Center